Take Our PhysQuiz on ACR Convergence 2020!
Test your knowledge on results on PsA released at ACR Convergence 2020 – take our quiz and...
cid1450
Take Our PhysQuiz on SABCS 2020!
Test your knowledge on SABCS 2020 – take our quiz and see how you compare with your...
SABCS 2020 eBook
SABCS Conference Report Featured: Update on Novel Agent from the DESTINY-Breast01 Trial How to Avoid Chemotherapy Overtreatment in Breast Cancer First Immunotherapy Combo Well-Tolerated Phase 3 MonarchE Trial: Efficacy...
Update on monarchE Trial: Abemaciclib Continues to Show Strong Efficacy
[flippingbook width=”100%” height=”auto” ratio=”3:2″ title=”Verzenio – MonarchE”]https://online.flippingbook.com/view/449874131/[/flippingbook] In an extended analysis of the...
SABCS 2020: How to avoid chemotherapy overtreatment in breast cancer
Certain patients with luminal early breast cancer and up to 3 involved lymph nodes can be treated with adjuvant endocrine therapy alone, according to the primary outcome analysis of the ADAPT HR+/HER2- trial (NCT01779206),...
SABCS 2020: First Immunotherapy Combo Well-Tolerated
In an interim analysis of the first immunotherapy combination phase 1b trial with trastuzumab deruxtecan, safety results showed nivolumab with trastuzumab deruxtecan was well tolerated in patients with HER2-positive or HER2-low...
SABCS 2020: Update from the DESTINY-Breast01 trial
In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer taking antibody-drug conjugate trastuzumab deruxtecan continued to demonstrate favorable efficacy data, durable...
SABCS 2020: Radiation Side-Effects Often Underrecognized in Patients With Breast Cancer
Acute side-effects of radiation therapy (RT) are often underrecognized by the physicians of...
SABCS 2020: Clinical & Genomic Data Combine for Improved Prognosis & Adjuvant Chemotherapy Guidance
An online tool (RSClin) incorporating clinical-pathologic data and results of the 21-gene...
SABCS 2020: Improved Outcomes With Neratinib-Based Regimens in CNS Metastases from HER2+ BC
Meeting Brief… A subgroup of patients participating in the randomized phase III NALA study...
SABCS 2020: Some Older Women With Breast Cancer May Opt to Skip Radiotherapy
The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast...
SABCS 2020: Pregnancy Less Likely After Breast Cancer Diagnosis
Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to a systematic...
